Immunogen (IMGN)

Add to Watchlists
Create an Alert
13.99 -0.22  -1.55% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
IMGN Price Chart
View All Events

IMGN Events

Date Type Description
Apr 25 Misc Immunogen, Inc. Q3 2014 Earnings Conference Call
Apr 25 Earnings Immunogen, Inc. Q3 2014 Earnings Results. Estimate: -0.29.
Jan 24 Misc 2q FY2014 Results Call
Jan 24 Earnings 2q FY2014 Results. Estimate: -0.18.
Nov 12 Misc AGM Event for Immunogen, Inc.
Oct 25 Misc Immunogen, Inc. Announces First Quarter 2014 Earnings Conference Call
Oct 25 Earnings 1q FY2014 Results Call. Estimate: -0.21.
Aug 02 Misc Immunogen, Inc. Announces Conference Call to Discuss Its Fourth Quarter and Fiscal Year 2013 Financial Results
Aug 02 Earnings 4q and FY2013 Results. Estimate: -0.30.
Apr 26 Misc Immunogen, Inc. Announces Conference Call to Discuss Its Third Quarter Fiscal Year 2013 Financial Results
View All Performance Charts

IMGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Immunogen is down 6.23% over the last year vs S&P 500 Total Return up 23.54%, Actelion up 72.03%, and Jazz Pharmaceuticals up 148.9%.

Get Quote for

PDF Report for IMGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download IMGN Pro Report PDF
Advertisement

Portfolio Strategies Featuring IMGN

Did Immunogen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IMGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Massachusetts
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

ImmunoGen, Inc. develops targeted anticancer therapeutics using our expertise in cancer biology, engineered antibodies and highly potent cancer-cell killing agents. The company's Targeted Antibody Payload technology uses monoclonal antibodies to deliver one of its proprietary cancer cell killing agents specifically to tumor cells. Its products include lorvotuzumab mertansine-IMGN901, trastuzumab emtansine-T-DM1, IMGN388, IMGN529, IMGN853 and SAR3419. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts. Its manufacturing facility is in Norwood, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
IMGN 13.99 -0.22 -1.55% 1.199B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.